Krystal Biotech Inc at JPMorgan Healthcare Conference Transcript
Good morning, everyone, and welcome. I hope you enjoyed the beginning of the conference. My name is Alex Buckley. I'm with the Healthcare Investment Banking Group at JPMorgan.
And it's my pleasure to introduce, firstly, Crystal Biotech. And joining us is Krish Krishnan, CEO and Chairman, and Suma Krishnan, President of R&D.
We'll have some time at the end for Q&A. If you could just raise your hand and a microphone will be passed around.
And with that, I will pass over to Krish and Suma to kick things off.
Good morning, everyone. Thanks for coming.
Thanks, Alex and JP Morgan for having us. This presentation, roughly about 20 minutes divided into two primary parts. I'll spend about 10 minutes or so talking about our thinking with respect to advancing crystal over the next 5 years.
And then Suma will follow-up and talk about the specific deliverables and objectives for
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
